Two registries will help further understanding of cardiac impacts of COVID-19
The American College of Cardiology (DC, USA) has announced it is to start collecting data, through two established registries, on the impacts of COVID-19 on individuals with heart disease.
The American College of Cardiology (DC, USA) has announced it is to start collecting data, through two established registries – the National Cardiovascular Data Registry (NCDR®; DC, USA) Chest Pain – MI™ Registry and the CathPCI Registry® – on the relationship between COVID-19 and heart disease, to aid understanding of cardiac impacts of the virus.
Both registries will now begin collecting data on the COVID-19 status of all included patients; for individuals who have or have had the virus, data on key biomarkers that may reflect cardiac impacts of the virus will also be collected, as well as information on hospital visits and use of COVID-19 therapies that may impact cardiac function.
Registries will play a key role in understanding how this virus influences the care and outcomes for individuals with heart disease, both now and in the future,”
– Frederick Masoudi, Chief Scientific Advisor at NCDR.
A key benefit of this initiative is that hospitals and healthcare systems already participating and contributing data to these two registries, will not need to join a new registry or engage in a new way to submit their data.
You may also be intesrested in:
- The relevance of registry and real-world data during the COVID-19 pandemic: an interview with Philip Robinson
- Utilizing registry data in benefit assessments of new drugs: the IQWiG perspective
- New registry launched to collect and share data on how COVID-19 affects individuals with rheumatic diseases
“We already collect high-quality clinical data to support hospitals in providing the highest quality care. Now it is critical to collect additional data that will provide key insights on the quality of care and outcomes of heart disease patients in the COVID-19 era,” concluded Masoudi.
Data pertaining to COVID-19-affected individuals from the beginning of the pandemic in the USA will be accepted for inclusion on the two registries; this will allow participating and joining hospitals and healthcare centers to track their patient care throughout COVID-19.
Further, in the future, long-term data harvested from the registries could allow researchers to investigate the impact of COVID-19 within specific racial, ethnic and gender subgroups.
Athena Poppas, President of the American College of Cardiology, stated: “We are learning every day how COVID-19 impacts our patients. By adapting our registries to answer pressing scientific questions and knowledge gaps, we can ensure that our cardiovascular care team has validated data and updated tools to provide the highest quality care particularly during these uncertain times.”